피하 주사기 및 주사 바늘 시장 - 유형별, 사용성별, 용도별, 최종 용도별 및 예측(2023-2032년)

Global Hypodermic Syringes & Needles Market is anticipated to register remarkable gains through 2032 on account of the surging prevalence of chronic disorders. As per the New York State Department of Health, in the U.S., heart disease causes around 697,000 deaths every year, which accounts for 1 in every 5 deaths. The growing disease burden has increased the number of surgeries, further escalating the need for hypodermic syringes & needles.

Overall, the hypodermic syringes & needles market is segmented in terms of type, usability, application, end-use, and region.

Based on usability, the hypodermic syringes & needles industry from the reusable segment is slated to register considerable gains through 2032, owing to the growing efforts of market players on new product innovations. Moreover, hypodermic reusable syringes and needles work well for the administration of injectable antibiotics and vaccines. In addition, a commendable rise in investments by government authorities in mega vaccination drives may further bolster segment growth.

In terms of application, the hypodermic syringes & needles industry from the vaccination segment is expected to grow at a substantial CAGR from 2023 to 2032, owing to the growing focus of government authorities on vaccination drives for public safety. In fact, in January 2022, Argentina implemented a National Vaccination Campaign in an effort to combat COVID-19 to restore in-person classes in schools. Likewise, the growing efforts of governments of developing economies to fight against infectious diseases are likely to pave the way for market expansion.

With respect to end-use, the hypodermic syringes & needles market from the diagnostic centers segment is slated to record a valuation of over USD 2 billion by 2032. A remarkable rise in the popularity of minimally invasive surgical procedures, such as core needle biopsy for pathological analysis of tissue samples, has bolstered the need for hypodermic syringes & needles in diagnostic centers. Moreover, these devices help obtain tissue samples by precisely targeting the area to be operated, leading to fewer postoperative complications and quick recovery.

From the regional perspective, the Asia Pacific hypodermic syringes & needles industry is poised to grow at over 4.5% CAGR from 2023 to 2032. The rising geriatric population, which is highly susceptible to diseases, has increased the frequency of visits to medical facilities, creating a strong demand for the product. As per WHO, an estimated 402 million people, which makes up 28% of the population in China will be over the age of 60 years by 2040.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Hypodermic syringes & needles industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Type trends
  • 2.1.3 Usability trends
  • 2.1.4 Application trends
  • 2.1.5 End-use trends
  • 2.1.6 Regional trends

Chapter 3 Hypodermic Syringes & Needles Industry Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic disorders
    • 3.2.1.2 Increase in the number of surgeries
    • 3.2.1.3 Increasing demand for syringes for mass vaccination
    • 3.2.1.4 Surged adoption of syringes & needles for blood collection
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Risk of needlestick injuries & infection
• 3.3 Growth potential analysis
  • 3.3.1 By type
  • 3.3.2 By usability
  • 3.3.3 By application
  • 3.3.4 By end-use
• 3.4 COVID-19 impact analysis
• 3.5 Technological advancements
• 3.6 Regulatory scenario
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Key market trends
• 3.8 Emerging alternatives
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Strategy dashboard, 2022

Chapter 5 Hypodermic Syringes & Needles Market, By Type

• 5.1 Key type trends
• 5.2 Syringes
  • 5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 5.3 Needles
  • 5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 6 Hypodermic Syringes & Needles Market, By Usability

• 6.1 Key usability trends
• 6.2 Disposable
  • 6.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 6.3 Reusable
  • 6.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 7 Hypodermic Syringes & Needles Market, By Application

• 7.1 Key application trends
• 7.2 Blood collection
  • 7.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 7.3 Drug delivery
  • 7.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 7.4 Vaccination
  • 7.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 7.5 Insulin administration
  • 7.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 7.6 Others
  • 7.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 8 Hypodermic Syringes & Needles Market, By End-use

• 8.1 Key end-use trends
• 8.2 Hospitals
  • 8.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 8.4 Diagnostic centers
  • 8.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
• 8.5 Others
  • 8.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 9 Hypodermic Syringes & Needles Market, By Region

• 9.1 Key region trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Poland
  • 9.3.7 Sweden
  • 9.3.8 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Indonesia
  • 9.4.7 Philippines
  • 9.4.8 Vietnam
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Colombia
  • 9.5.5 Chile
  • 9.5.6 Peru
  • 9.5.7 Uruguay
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Turkey
  • 9.6.5 Israel
  • 9.6.6 Egypt

Chapter 10 Company Profiles

• 10.1 Smiths Medical (ICU Medical)
• 10.2 B. Braun Medical, Inc.
• 10.3 Becton Dickinson, & Company
• 10.4 Cardinal Health, Inc.
• 10.5 Terumo Corporation
• 10.6 Nipro Corporation
• 10.7 Lifelong Meditech Private Limited
• 10.8 Retractable Technologies
• 10.9 CONNECTICUT HYPODERMICS INC.
• 10.10 McKesson Corporation
• 10.11 Medline Industries, Inc.
• 10.12 Vita Needle Company
• 10.13 Exelint International
• 10.14 Vitrex Medical A/S
• 10.15 Hi-Tech Syringes Pvt Ltd.